The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploratory analysis of left- versus right-sided colorectal carcinoma in RAISE: A randomized, double-blind, phase 3 trial of ramucirumab (RAM) + FOLFIRI versus placebo (PBO) + FOLFIRI.
 
David Craig Portnoy
Employment - CNS Healthcare (I)
Research Funding - Lilly
 
Radka Obermannova
Honoraria - Amgen; Lilly; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Lilly
 
Gyorgy Bodoky
Travel, Accommodations, Expenses - Lilly; Pfizer
 
Jana Prausová
No Relationships to Disclose
 
Rocio Garcia-Carbonero
Honoraria - Amgen (I); Boehringer Ingelheim (I); Lilly (I); Merck (I); Novartis (I); Pfizer (I); Roche (I)
Consulting or Advisory Role - AstraZeneca (I); Boehringer Ingelheim (I); Bristol-Myers Squibb (I); Lilly (I); Merck Sharp & Dohme (I); Novartis (I); Pfizer (I); Roche (I)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim (I); Ipsen; Lilly (I); Merck; Novartis; Pfizer; Pfizer (I); Roche; Roche (I); Sanofi
 
Tudor-Eliade Ciuleanu
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; BMS Brazil; Boehringer Ingelheim; GlaxoSmithKline/Novartis; Janssen; Lilly; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche; Sanofi; Teva
Travel, Accommodations, Expenses - Amgen (I); Boehringer Ingelheim (I); Ipsen (I); Janssen (I); Merck (I); Pfizer (I); Sanofi (I); Servier (I)
 
Pilar Garcia Alfonso
No Relationships to Disclose
 
Allen Lee Cohn
Honoraria - Medimmune; Taiho Pharmaceutical
Speakers' Bureau - Medimmune; Taiho Pharmaceutical
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Kentaro Yamazaki
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Bristol-Myers Squibb Japan (Inst); Sanofi (Inst)
 
Takayuki Yoshino
Research Funding - Boehringer Ingelheim; GlaxoSmithKline
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Bayer
Speakers' Bureau - Lilly; Roche
Research Funding - Sanofi
 
Tae Won Kim
Honoraria - Amgen; Lilly
Research Funding - Bayer (Inst)
 
Kensei Yamaguchi
Speakers' Bureau - Chugai Pharma; Lilly; Merck; Taiho Pharmaceutical; Takeda
Research Funding - Chugai Pharma; Lilly; Merck; MSD; Taiho Pharmaceutical; Yakult Honsha
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche
 
Juan Manuel O Connor
Consulting or Advisory Role - Bayer; Lilly; Merck Serono; Raffo
 
Yanzhi Hsu
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
David Ferry
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Federico Nasroulah
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Travel, Accommodations, Expenses - Lilly
Other Relationship - Lilly
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Celgene; Chugai Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche; Sanofi; Symphony Evolution; Taiho Pharmaceutical; Takeda